A detailed history of Virtu Financial LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 100,406 shares of CTXR stock, worth $260,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,406
Holding current value
$260,051
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$0.48 - $1.02 $48,194 - $102,414
100,406 New
100,406 $50,000
Q4 2023

Feb 26, 2024

BUY
$0.65 - $0.86 $33,455 - $44,264
51,470 New
51,470 $39,000
Q2 2023

Jul 27, 2023

BUY
$1.08 - $1.65 $25,753 - $39,345
23,846 New
23,846 $29,000
Q4 2022

Feb 15, 2023

BUY
$0.79 - $1.28 $30,813 - $49,926
39,005 New
39,005 $31,000
Q2 2022

Aug 09, 2022

BUY
$0.88 - $1.87 $71,640 - $152,236
81,410 New
81,410 $75,000
Q3 2021

Nov 12, 2021

SELL
$1.74 - $2.6 $34,300 - $51,253
-19,713 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$1.51 - $4.23 $29,766 - $83,385
19,713 New
19,713 $69,000
Q1 2021

May 19, 2021

SELL
$1.04 - $2.34 $153,569 - $345,531
-147,663 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$0.9 - $1.2 $30,096 - $40,128
33,440 Added 29.28%
147,663 $151,000
Q3 2020

Dec 11, 2020

BUY
$0.83 - $1.51 $18,616 - $33,869
22,430 Added 24.44%
114,223 $119,000
Q2 2020

Aug 07, 2020

BUY
$0.65 - $1.45 $59,665 - $133,099
91,793 New
91,793 $104,000
Q4 2019

Feb 04, 2020

SELL
$0.42 - $1.15 $6,937 - $18,996
-16,519 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$0.72 - $1.38 $11,893 - $22,796
16,519 New
16,519 $13,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $378M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.